Amgen (AMGN) Cash Flow Statement

Click line-items for a historical chart and %

Net income	5.79B
Depreciation and amortization	1.55B
Stock-based compensation expense	222M
Deferred income taxes
Property, plant and equipment impairments
Dividend received from equity investee
Other items, net
Trade receivables, net	-192M
Inventories	-125M
Other current assets	-335M
Accounts payable	-147M
Accrued income taxes	-140M
Other accrued liabilities
Net cash provided by operating activities	7.25B
Purchases of property, plant and equipment	-511M
Cash paid for acquisitions, net of cash acquired
Purchases of marketable securities	-22.68B
Proceeds from sales of marketable securities	14.07B
Proceeds from maturities of marketable securities	1.93B
Other	-262M
Net cash used in investing activities	-7.44B
Repurchases of common stock	-1.98B
Repayment of debt	-2.73B
Net proceeds from issuance of debt	6.71B
Net proceeds from issuance of common stock in connection with the Company's equity award programs
Other	22M
Net cash used in financing activities	-477M
Increase (decrease) in cash and cash equivalents	-659M
Cash and cash equivalents at beginning of period	4.14B
Cash and cash equivalents at end of period	3.49B

Entities mentioned with AMGN

View All Entities